Dr. Craddock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8731 Katy Fwy
Ste 200
Houston, TX 77024Phone+1 832-678-8333Fax+1 713-467-0965
Summary
- I am a board-certified otolaryngologist specializing in adult and pediatric general ear, nose & throat (ENT) issues. I completed my fellowship in otolaryngic allergy and focus on the treatment of inhalant allergies, rhinology/sinus disease, and sleep medicine (apnea, snoring, nasal airway obstruction, tonsil/adenoid hypertrophy). I earned my MD degree and completed my residency training at The University of Texas Houston Medical School.
In 2000 I joined Rosewood ENT which subsequently merged with Texas ENT Specialists in Houston, Texas.
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2005 - 2008
- Naval Medical Center (San Diego)Residency, Pediatrics, 1999 - 2001
- University of Texas Health Science Center at HoustonResidency, Otolaryngology - Head and Neck Surgery, 1995 - 2000
- UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1995
- McGovern Medical School at UTHealthClass of 1995
Certifications & Licensure
- TX State Medical License 1996 - 2024
- CO State Medical License 2011 - 2021
- MD State Medical License 1997 - 2014
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
- American Board of Otolaryngic AllergyFellow
Clinical Trials
- Natural History Study of SCID Disorders Start of enrollment: 2010 Sep 02
- Patients Treated for SCID (1968-Present) Start of enrollment: 2011 May 15
- Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 Start of enrollment: 2014 Feb 02
Publications & Presentations
PubMed
- 381 citationsEnhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2bJohn Craddock, An Lu, Adham S. Bear, Martin Pule, Malcolm K. Brenner
Journal of Immunotherapy. 2010-10-01 - 112 citationsSCID genotype and 6-month posttransplant CD4 count predict survival and immune recoveryElie Haddad, Brent R. Logan, Linda M. Griffith, Rebecca H. Buckley, Roberta E. Parrott
Blood. 2018-10-25 - 171 citationsSafety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem ce...Ulrike Gerdemann, Usha L. Katari, Anastasia Papadopoulou, Jacqueline M. Keirnan, John Craddock
Molecular Therapy. 2013-11-01
Committees
- Member, American Academy of Otolaryngic Allergy Patient & Professional Relations Committee 2018 - Present
Professional Memberships
- Fellow
- Fellow
- Harris County Medical SocietyMember
- Texas Medical AssociationMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: